BACHEM N -B- | 381,00 / -1,93% |
Fecha/Hora | 15.01. / 17:31 |
Dif. / Dif.(%) | -7,50 / -1,93% |
Bid | - / 32 |
Ask | 386,00 / 234 |
Apertura | 387,50 |
Cierre del día anterior | 388,50 |
Máxima sesión | 387,50 |
Mínima sesión | 375,00 |
Volumen [CHF] | 6.835.297,75 |
Volumen [Unidades] | 17.930 |
Fijación de precios | 777 |
ISIN | CH0012530207 |
Símbolo | BANB |
Bolsa | SIX Swiss Exchange |
Tipo | Stock |
Bolsa | Último | Volumen | |
---|---|---|---|
SIX Swiss Ex.. | 381,00 | ![]() |
17.930 |
London Inter.. | 381,00 | ![]() |
57 |
Lang & Schwa.. | 348,50 | ![]() |
|
Nasdaq Other.. | 418,0000 | 48 | |
Cboe Europe .. | 129,20 | 126 | |
Cboe Europe .. | 128,80 | 58 | |
Turquoise | 128,80 | ![]() |
13 |
Frankfurt | 115,0000 | 0 | |
Berlin | 116,20 | 0 | |
München | 114,80 | 0 | |
Hamburg | 114,80 | 0 | |
EUREX | Opciones |
Noticias
- Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome
14.05.2020 / 07:00 - GlobeNewswire - Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
04.05.2020 / 14:30 - GlobeNewswire - Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Trial
28.04.2020 / 15:24 - GlobeNewswire - Vaccine Contract Manufacturing Market, 2030 - Market is Anticipated to Generate Revenues Worth USD 100 Billion by 2025
04.10.2019 / 10:05 - GlobeNewswire - Global Pharmaceutical Contract Manufacturing Market 2018-2025 - Patent Expiration Of Small Molecules Drugs & Advanced Technologies In API And FDF Manufacturing
26.03.2019 / 10:57 - GlobeNewswire